Alliance A041703
Alliance A041703: Phase II Trial of Inotuzumab Ozogamicin Induction Followed by Blinatumomab Consolidation for Older Adults With Newly Diagnosed Ph-Negative, CD22-Positive B-ALL

Released: June 12, 2023

Activity

Progress
1
Course Completed